Literature DB >> 26081561

Neurologic Complications of Chronic Kidney Disease.

Kavitha Vellanki1, Vinod K Bansal.   

Abstract

Chronic kidney disease (CKD) is an increasing problem worldwide and is now being recognized as a global health burden particularly for cardiovascular and cerebrovascular events. The incidence of stroke increases in the presence of CKD with a 3-fold increased rate reported in ESRD. Atrial fibrillation (AF) increases the risk of stroke in CKD. There is conflicting observational evidence regarding benefit of anticoagulation in CKD for prevention of stroke in AF as risk of bleeding is high. Overall, anticoagulant in CKD may be beneficial in appropriate patients with meticulous monitoring of international normalized ratio (INR). Neurological manifestations related to electrolyte disorders, drug toxicity, and uremia are common in CKD. Appropriate drug dosing, awareness of potential side effects of medications, prompt diagnosis, and treatment are essential in preventing long-term morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26081561     DOI: 10.1007/s11910-015-0577-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  58 in total

1.  Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.

Authors:  Mitesh Shah; Meytal Avgil Tsadok; Cynthia A Jackevicius; Vidal Essebag; Mark J Eisenberg; Elham Rahme; Karin H Humphries; Jack V Tu; Hassan Behlouli; Helen Guo; Louise Pilote
Journal:  Circulation       Date:  2014-01-22       Impact factor: 29.690

Review 2.  Disorders of plasma sodium--causes, consequences, and correction.

Authors:  Richard H Sterns
Journal:  N Engl J Med       Date:  2015-01-01       Impact factor: 91.245

3.  Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study.

Authors:  Albert Power; Kakit Chan; Seema K Singh; David Taube; Neill Duncan
Journal:  Am J Kidney Dis       Date:  2011-09-23       Impact factor: 8.860

4.  Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.

Authors:  Takeshi Horio; Yoshio Iwashima; Kei Kamide; Takeshi Tokudome; Fumiki Yoshihara; Satoko Nakamura; Yuhei Kawano
Journal:  J Hypertens       Date:  2010-08       Impact factor: 4.844

Review 5.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

6.  Chronic kidney disease in patients with acute intracerebral hemorrhage: association with large hematoma volume and poor outcome.

Authors:  Noa Molshatzki; David Orion; Rakefet Tsabari; Yvonne Schwammenthal; Oleg Merzeliak; Maya Toashi; David Tanne
Journal:  Cerebrovasc Dis       Date:  2010-12-21       Impact factor: 2.762

7.  Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.

Authors:  Keiko Nakagawa; Tadakazu Hirai; Shutaro Takashima; Nobuyuki Fukuda; Kazumasa Ohara; Etsuko Sasahara; Yoshiharu Taguchi; Nobuhiro Dougu; Takashi Nozawa; Kortaro Tanaka; Hiroshi Inoue
Journal:  Am J Cardiol       Date:  2011-01-19       Impact factor: 2.778

Review 8.  Mechanisms of acute uremic encephalopathy: early activation of Fos and Fra-2 gene products in different nuclei/areas of the rat brain.

Authors:  August Heidland; Katarina Sebekova; André Klassen; Miklós Palkovits
Journal:  J Ren Nutr       Date:  2010-09       Impact factor: 3.655

9.  Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study.

Authors:  Stephen M Sozio; Paige A Armstrong; Josef Coresh; Bernard G Jaar; Nancy E Fink; Laura C Plantinga; Neil R Powe; Rulan S Parekh
Journal:  Am J Kidney Dis       Date:  2009-04-19       Impact factor: 8.860

10.  Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage.

Authors:  Bruce Ovbiagele; Jeffrey J Wing; Ravi S Menon; Richard E Burgess; M Christopher Gibbons; Ian Sobotka; Laura German; Nawar M Shara; Stephen Fernandez; Annapurni Jayam-Trouth; Dorothy Farrar Edwards; Chelsea S Kidwell
Journal:  Stroke       Date:  2013-07-11       Impact factor: 7.914

View more
  1 in total

1.  Glymphatic Dysfunction in Patients With End-Stage Renal Disease.

Authors:  Chang Min Heo; Won Ho Lee; Bong Soo Park; Yoo Jin Lee; Sihyung Park; Yang Wook Kim; Dong Ah Lee; Byeong Cheol Yoo; Kang Min Park
Journal:  Front Neurol       Date:  2022-01-25       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.